used tibial nerve SEPs for this purpose. Furthermore, the value of SEPs in patients with SAH as a distinct group has not been addressed yet. Therefore, we designed this prospective study to analyze SEPs in patients with high-grade SAH at 2 different points to investigate their correlation with long-term clinical outcome and compare them with the established clinical parameters. Another goal of this study was to determine whether tibial nerve SEPs can add useful information regarding clinical outcome.
Methods

Patient Population
Every patient with SAH who was admitted to the intensive care unit of the University Medical Center HamburgEppendorf between January 2013 and January 2015 was screened for this study. Included were patients older than 18 years with newly diagnosed SAH, Grade III or higher on the Hunt and Hess (HH) scale, 10 if the hemorrhage took place within 3 days before admission. Patients with recurrent hemorrhage, concomitant trauma, or preexisting myelopathy or polyneuropathy were excluded from the study.
Each patient was admitted to the intensive care unit and underwent at least 1 CT study at the time of admission. Ventriculostomy was performed when clinical signs of hydrocephalus were present or hydrocephalus was visible on the CT scan. Afterward, aneurysm repair was performed by either endovascular or microsurgical means based on the decision of an interdisciplinary board that included a team of senior neurosurgeons and interventional neuroradiologists. After aneurysm repair, the goal of treatment was to reduce sedation and attempt to extubate the patient when possible to enable clinical evaluation. In addition to normovolemia and maintenance of a mean arterial blood pressure higher than 90 mm Hg, each patient was treated with intravenous nimodipine for the 1st week after the hemorrhage and then oral nimodipine for 2 weeks. We screened for vasospasm by performing transcranial Doppler ultrasonography daily; if mean flow velocity increased by 50 cm/sec or 100% within 24 hours or if a threshold of 200 cm/sec was exceeded, cerebral angiography was performed, and intraarterial nimodipine was administered when vasospasm was detected. After the acute treatment period, patients were referred to a specialized neurorehabilitation unit either directly or after a short stay in the neurological or neurosurgical ward.
Clinical Parameters
Basic demographic data, initial Glasgow Coma Scale (GCS) score, 11, 21 HH grade, and blood distribution on initial CT scans according to the Fisher scale were recorded. To determine patient outcome, the Glasgow Outcome Scale (GOS) score was determined at discharge and at the 6-month follow-up visit. For statistical analysis, dichotomization was used (good outcome [GOS score of 4 or 5] or poor outcome [GOS score of 1, 2, or 3]).
Somatosensory Evoked Potentials
Bedside recording of SEPs from the right and left median nerves and from the right and left tibial nerves was performed within 3 days after hemorrhage and repeated 14 days later. Measurements were performed by a medical technologist with dedicated training in neurophysiological diagnosis using the Nihon Kohden system (Neuropack M1 and polaris.one); a dual-channel setup for the median nerve and single-channel setup for the tibial nerve were used. Stimulus rates of 2 and 3 Hz were used for median and tibial nerve SEPs, respectively. The stimulus intensity was set at 3 mA over the threshold that elicited a visible twitch of the thumb or toe muscles with a pulse duration of 0.2 msec. An average of 100-200 responses were recorded with at least 2 repetitions to gain reproducible waveforms. The analysis time was 100 msec, and the bandwidth was 3-5 kHz. Recording electrodes were placed at Erb's point and the left postcentral (C3′), right postcentral (C4′), and midline postcentral (Cz′) regions of the scalp, in reference to the midline frontal (Fz) scalp, according to the 10-20 International System. For the median nerve, latencies of N10 and N20 waves, interpeak latencies, and peak-to-peak amplitude of the N20 component were measured. For tibial nerve SEPs, latency and peak-to-peak amplitude of the P40 component were measured.
Normal limits were defined (using standardized values determined from a healthy cohort) as an interpeak N10-N20 latency of 19.2 ± 0.9 msec, an N20 component amplitude of 1.3 ± 0.6 μV, a P40 latency of 38.8 ± 2.0 msec, and a P40 component amplitude of 1.8 ± 1.3 μV. 23 Evaluation of the SEP measurements was performed by a neurological consultant who was blinded to the clinical course of the patients. Results were dichotomized as present or missing cortical responses and normal or prolonged latencies for each nerve and side. Similar to the determination of a score proposed by Firsching and Frowein 8 and to better reproduce the integrity of the whole nervous system, each normal result was given 1 point. The points then were grouped and summed to result in a score that ranged from 0 to 8 for each measurement (4× cortical responses and 4× latencies) and used for statistical analysis.
Statistical Analysis
Statistics were analyzed using IBM SPSS v23 and v24 (IBM Corp.) and R v2.3.5 (R Foundation). For basic analysis of SEP latencies, the Student t-test was used, and univariate ANOVA was used for outcome analysis. Concerning dichotomized and summarized variables, we used multiple binary regression analysis with outcomes dichotomized as good (GOS score of 4 or 5) or poor (GOS score of 1, 2, or 3). In the analysis of outcome prediction, we always used the GOS score at the 6-month follow-up visit as the outcome variable. To evaluate the sensitivity and specificity of the predictive variables, we used receiver operating characteristic (ROC) curves. The results were calculated with corresponding 95% confidence intervals. Significance was defined as a p value ≤ 0.05.
Ethics Statement
In accordance with local and institutional laws and dataprotection regulations, approval by the local ethics committee was obtained and archived. The study was performed in accordance with the ethical standards provided in the 1964 Declaration of Helsinki and its later amendments.
Results
A total of 48 patients with high-grade aneurysmal SAH (HH Grade III or higher) were enrolled in the study. This total included 22 patients whose status was HH Grade III, 13 whose status was HH Grade IV, and 13 whose status was HH Grade V. Their mean age was 58 years (range 28-81 years); 34 patients were female, and 14 were male. The median length of stay was 31.4 days (range 5-75 days). Twelve patients underwent aneurysm clipping, and 36 were treated using endovascular means (Table 1) .
At discharge, outcome was deemed good in 27.1% (13 of 48) of the patients and poor in 72.9% (35 of 48); 10.4% (5 of 48) of the patients died before discharge. At the follow-up visit, outcomes were good in 60.4% (29 of 48) of the patients and poor in 39.6% (n = 19). One patient with a GOS score of 2 at discharge died within the follow-up period; compared with their GOS scores at discharge, the scores in all of the other patients had either stabilized or improved (56.3% [27 of 48]) ( Table 2) .
The first measurements of SEPs were made in 46 patients (2 ± 1 day after hemorrhage), and the second measurement was made in 41 patients (14 ± 1 day after hemorrhage). Primary measurements were not obtained in 2 patients and secondary measurements were not obtained in 7 patients because of compliance issues. Thirty-nine (81.3%) patients received sedation (propofol and midazolam) at the first SEP measurement, and this number was reduced at the second measurement to 6 (12.5%). We found no significant differences in absolute SEP latencies or cortical responses between patients with and those without sedation in a 1-way ANOVA for Measurements 1 and 2. Also, the results of multivariate (see below) and univariate regressions (Measurement 1, B = -1.5, p = 0.07; Measurement 2, B = -0.2, p = 0.84) did not confirm a significant impact of sedation on calculated SEP scores.
In the first SEP measurements, the mean N20 latencies 
Analysis
When only the presence of cortical responses was analyzed, no patient with a GOS score of 4 or 5 at follow-up had missing responses on median SEPs in Measurement 1 or 2, whereas in the group of patients with a GOS score of 1, 2, or 3, 35.7% and 28.6% had missing responses on median SEPs in Measurements 1 and 2, respectively (p = 0.014). Cortical responses for the lower extremities did not correlate with clinical outcome in Measurement 1, but in Measurement 2, 7.7% in the good-outcome group had at least 1 missing response versus 64.3% in the poor-outcome group (p = 0.001). When we analyzed the latencies of the arms at Measurement 1, we identified no significant differences between outcome groups, whereas in Measurement 2, no patient in the good-outcome group had abnormal latencies in both arms, and 18.5% had abnormal latencies in 1 arm. In contrast, 64.3% in the poor-outcome group had abnormal latencies, 28.6% in both arms and 35.7% in 1 arm (p = 0.003). In the lower extremities, 23% in the good-outcome group had abnormal latencies in both legs and 19.2% had abnormal latencies in 1 leg, whereas in the poor-outcome group, 64.3% had abnormal latencies in both legs and 21.4% had them in 1 leg (p = 0.034).
One-way ANOVA did not identify any significant correlation between P40 or N20 amplitudes or latencies and clinical outcome, regardless of the measurement point, and the intergroup differences were not significant.
Calculated SEP Scores
Patients with a GOS score of 1 or 2 had median scores of 4 (range 2-7) in the first measurement and 1 (range 0-2) in the second measurement. Patients with a GOS score of 3 had median scores of 5 (range 2-7) in the first measurement and 6 (range 0-7) in the second measurement. Patients with a GOS score of 4 or 5 had median scores of 6 (range 3-7) in the first measurement and 7 (range 4-8) in the second measurement.
In summary, in regard to cortical and latency scores, we found no significant difference in the score distributions when patient outcomes were dichotomized in cross tables and tested by Pearson's chi-square test for Measurement 1 (Fig. 1) . However, in Measurement 2, a significant difference in the distributions of both scores was identified (cortical responses, p = 0.004; latency, p = 0.008; chi-square) (Fig. 1) . The mean scores in both cases were significantly higher in the good-outcome group than in the poor-outcome group (latencies in Measurement 2, 3.1 vs 1.6 points, respectively [p = 0.002]; cortical responses in Measurement 2, 3.8 vs 2.4, respectively [p < 0.001, t-test]).
When we analyzed cumulative cortical and latency scores, we identified no significant correlation between values in Measurement 1 and patient outcome. In multiple binary backward regression including the variables cumulative score, patient age, HH grade, GCS score, and presence of sedation, the only variable associated with poor outcome was the cumulative scores for Measurement 2 (OR 0.39, p = 0.005) (Fig. 2) , the impact of which was confirmed in forward binary regression. (Fig. 3) .
Overall SEPs in the first measurement had an AUC of 0.64 (95% CI 0.47-0.80, p = 0.11) and in the second measurement an AUC of 0.82 (95% CI 0.68-0.97, p < 0.01). 
Vasospasm
Vasospasm, as detected by transcranial Doppler ultrasonography, CT, or conventional angiography, was apparent at least once during the treatment of 68.8% (33 of 48) of the patients. Patients with poor outcome experienced vasospasm significantly more often than those with good outcome (84.2% vs 58.6%, respectively; OR 3.8; p = 0.05). If delayed cerebral ischemia resulted from vasospasm (overall rate 62.5%), this effect was even more obvious (89.5% vs 44.8%, respectively; OR 10.5; p < 0.01).
Discussion
SEPs as an electrophysiological diagnostic tool have been well described in the context of outcome prediction in comatose patients after cardiac arrest or traumatic brain injury. 5, 15, 18, 20 The main use of SEPs in these series was for the prediction of the likelihood of not awakening from coma, and the most important predictor seems to be the absence of cortical responses (N20 waves). We analyzed SEPs in a cohort of patients with high-grade SAH, a disease in which patient recovery depends not only on the degree of primary brain damage but also the secondary complications that result from the hemorrhage. In our series, patients who did not recover from coma (GOS score of 1 or 2) had either no cortical response or no more than 1 cortical response with or without normal latency. One patient did not show any cortical responses (SEP score of 0) in the second measurement and had a GOS score of 3, which does not support the 100% specificity found in other series for missing cortical responses always being associated with not awaking from coma. 14, 15, 20 Although admitted with a high-grade SAH, most patients in our series had a favorable outcome (GOS score of 4 or 5) at the 6-month follow-up visit. In the second measurement, the presence of bilateral cortical responses was associated with a favorable outcome on median and tibial nerve SEPs (sensitivities 100% and 92% and specificities 71% and 64%, respectively). Bilateral normal latencies also were associated with a favorable outcome on median and tibial nerve SEPs (sensitivities 100% and 77%, respectively, and specificity 64% for both). In our multivariate analysis, every cortical response or normal latency was represented with 1 point, following a scoring system for SEPs used by Firsching and Frowein, 8 which resulted in a score that ranges from 0 to 8. Our analysis revealed that the score was associated with clinical outcome, and this association was found also when cortical responses or latencies from all extremities and cortical responses and latencies from median or tibial nerves were tested separately (Figs. 2 and 3) . We did not involve the amplitude measurement in the calculated score because it is known to be subject to wide interindividual variability 19 and to avoid further complication of the scoring system.
In some studies, measurement of amplitudes was proposed to be helpful because amplitude reduction in early SEPs was associated with no recovery, whereas latencies did not add prognostic information. 13 In other studies, prolonged latencies were associated with poor recovery. 14, 20 Neither absolute values of amplitudes nor those of latencies in the first or second measurement correlated with the clinical outcome in our patient cohort, which might underline the difference between SAH and other etiologies of brain damage and supports the finding of Logi et al., 13 who evaluated SEPs in patients in a coma of different etiologies and concluded that these different etiologies were associated with different electrophysiological patterns of SEPs.
Another goal of this study was to determine the most useful point at which to measure SEPs to gain reliable information about potential recovery in patients with highgrade SAH. We chose the first time point to be within 3 days after hemorrhage, because the primary brain damage that results from SAH should have taken place by then. Each patient in our cohort suffered from a high-grade SAH, and therefore, most of them (81.3%) were under sedation during the first SEP measurement. In the study design, to avoid the risk of elevated intracranial pressure, we decided not to interrupt sedation to perform the measurement. When we evaluated median nerve SEPs, the only significant correlation was found in the univariate analysis between the presence of cortical responses and a favorable long-term outcome, because none of the patients with a GOS score of 4 or 5 at the 6-month follow-up had missing cortical responses. This correlation could not be confirmed in the multivariate analysis. Neither the presence of cortical responses nor their latencies on tibial nerve SEPs were informative regarding outcome.
SEPs are known to be relatively robust to the influence of anesthetic agents, 3 and they are widely used during intraoperative monitoring. 1, 6, 22 However, sedatives were found to cause significant reduction of amplitude and prolongation of latencies in SEPs compared with SEPs measured in awake patients, 9, 12 which, from our point of view, might limit the use of SEPs for outcome prediction in patients under sedation. However, this fact does not explain why early SEP measurement was not conclusive in our study, because the presence of cortical responses, which should not be affected by sedation, was not associated with clinical outcome in the multivariate analysis. Moreover, univariate and multivariate regressions did not reveal an impact of sedation on calculated SEP scores. A more convincing explanation would be the fact that delayed cerebral ischemia resulting from vasospasm took place in 62.5% of the patients within the first 2 weeks and affected their outcome significantly (OR 10.5, p < 0.01). Therefore, we recommend SEP measurements to be made 2 weeks after hemorrhage to gain reliable information about long-term outcome.
Because of the intensive care unit setting and the difficulties in positioning patients at risk for developing elevated intracranial pressure, recording of N22 SEPs at the lumbar level was not performed, which probably led us to miss prolonged latencies of the P40 component that resulted from peripheral nerve damage, which limits the interpretation of latencies in the measurement of tibial nerve SEPs in this series; however, none of the included patients suffered from trauma or a previously known myelopathy or neuropathy. Nevertheless, measurement of tibial nerve SEPs was valuable in this series, because not only normal or prolonged latencies but also the presence or absence of cortical responses were associated with patient outcome. In addition, the calculated score on the second measurement of tibial nerve SEPs had a high sensitivity and specificity for outcome prediction (AUC 0.81) and thus performed better than median nerve SEPs (AUC 0.76). The interpretation of tibial nerve SEPs toward the ability of patients to move independently would be interesting but was not addressed in this series because of the limited value of the applied outcome measurement in this regard.
In addition to the relatively small number of the included patients in this study, the missing first SEP measurement in 2 patients and the second measurement in 7 patients are limitations that must be considered when interpreting our results.
Conclusions
Early SEP measurement after SAH was not predictive of outcome in our patient cohort, but SEP measurements of the median and tibial nerves 2 weeks after hemorrhage were associated with long-term outcome in patients with high-grade SAH and might be useful in clinical practice for estimating recovery potential in this group of patients.
